Monday, May 6, 2024
HomeHealthcareHospital and illnessImmunocore and Medison Pharma collaborate to market Tebentafusp in Canada
Image credit: labiotech.eu,
Hospital and illness

Immunocore and Medison Pharma collaborate to market Tebentafusp in Canada

Sarojini P
By Sarojini P

-

Ontario, Canada (CU)_ Immunocore, which is a late-stage biotechnology firm creating a unique class of bispecific T cell receptor (TCR) bispecific immunotherapies for the treatment of a variety of diseases, including…

spot_img
Previous article
Indian American political expert becomes White House staff secretary
Next article
Poorer Peterborough students much less likely to go to university
Sarojini P
Sarojini Phttps://www.commonwealthunion.com/

LEAVE A REPLY

Please enter your comment!
Please enter your name here

LATEST POSTS

Follow us

51,000FansLike
50FollowersFollow
428SubscribersSubscribe
spot_img

First and only digital business platform reaching out to 2.4 billion in the Commonwealth.

Contact us: info@commonwealthunion.com

Trending

Categories

© All rights reserved by Commonwealth Union

MORE STORIES
India

More companies set up in March

Hafsah Zuhar - 0
According to official data last fiscal, more than 185,000 companies were registered in the country which is higher than the last few years, and...